Giuseppe
Emeritus
The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey (abstract, edited)
[Source: Eurosurveillance, full text: <cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730">Eurosurveillance - View Article</cite>. Abstract, edited.]
Eurosurveillance, Volume 15, Issue 47, 25 November 2010
Rapid communications
The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey
F Dorleans 1, C Giambi 2, L Dematte 3, S Cotter 4, P Stefanoff 5, J Mereckiene 4, D O?Flanagan 4, P L Lopalco 6, F D'Ancona 2, D L?vy-Bruhl 1, on behalf of the VENICE 2 project gatekeepers group 7
1. Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France
2. National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanit? (ISS, National Institute of Health), Rome, Italy
3. CINECA Consortium of Universities, Bologna, Italy
4. Health Protection Surveillance Centre (HPSC), Dublin, Ireland
5. National Institute of Public Heath- National Institute of Hygiene, Warsaw, Poland
6. Scientific Advice Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
7. The members of the group are listed at the end of the article
Citation style for this article: Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O?Flanagan D, Lopalco PL, D'Ancona F, L?vy-Bruhl D, on behalf of the VENICE 2 project gatekeepers group. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill. 2010;15(47)
ii=19730. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730
Date of submission: 05 November 2010
The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination.
-
------<cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730"></cite>
[Source: Eurosurveillance, full text: <cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730">Eurosurveillance - View Article</cite>. Abstract, edited.]
Eurosurveillance, Volume 15, Issue 47, 25 November 2010
Rapid communications
The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey
F Dorleans 1, C Giambi 2, L Dematte 3, S Cotter 4, P Stefanoff 5, J Mereckiene 4, D O?Flanagan 4, P L Lopalco 6, F D'Ancona 2, D L?vy-Bruhl 1, on behalf of the VENICE 2 project gatekeepers group 7
1. Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France
2. National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanit? (ISS, National Institute of Health), Rome, Italy
3. CINECA Consortium of Universities, Bologna, Italy
4. Health Protection Surveillance Centre (HPSC), Dublin, Ireland
5. National Institute of Public Heath- National Institute of Hygiene, Warsaw, Poland
6. Scientific Advice Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
7. The members of the group are listed at the end of the article
Citation style for this article: Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O?Flanagan D, Lopalco PL, D'Ancona F, L?vy-Bruhl D, on behalf of the VENICE 2 project gatekeepers group. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill. 2010;15(47)
ii=19730. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730Date of submission: 05 November 2010
The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination.
-
------<cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730"></cite>